Drugs Made In America Acquisition (DMIIR) Notes Payables (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Notes Payables of $250100.0 for Q4 2024.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Notes Payables (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Notes Payables for 1 consecutive years, with $250100.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Notes Payables changed N/A year-over-year to $250100.0; the TTM figure through Dec 2024 stood at $250100.0 (changed N/A YoY), while the FY2024 annual figure was $250100.0, changed N/A from the prior year.
- Notes Payables held at $250100.0 in Q4 2024 per DMIIR's latest filing.
- Across five years, Notes Payables topped out at $250100.0 in Q4 2024 and bottomed at $250100.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - |